The U.S. Food and Drug Administration on Wednesday sent its first-ever warning letters to companies selling products containing Delta-8 THC, the hemp-derived, increasingly popular cannabinoid-cousin of the better-known Delta-9 THC.

The letters say the companies made unsubstantiated medical-benefits claims about the goods, failed to advise a proper dosage or improperly included Delta-8 in food.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]